Reply to Cho, P.S.P. Comment on “Kardos et al. Efficacy and Safety of a Single Ivy Extract Versus Two Herbal Extract Combinations in Patients with Acute Bronchitis: A Multi-Center, Randomized, Open-Label Clinical Trial. Pharmaceuticals 2025, 18, 754” [PDF]
PharmaceuticalsFirstly, we would like to thank the author of the letter [...]
Peter Kardos +4 more
doaj +2 more sources
An Epidemiological Study on the Effectiveness of Nasturtium Herb and Horseradish Root (Angocin® Anti-Infekt N) as well as Other Phytopharmaceuticals, Synthetic Products, and Antibiotics on the Course of Acute Upper Respiratory Tract Infection (aURTI) [PDF]
AntibioticsBackground: The goal of this study was to evaluate whether medical recommendation of Angocin® Anti-Infekt N (hereafter referred to as Angocin®) on the day of diagnosis of an acute upper respiratory tract infection (aURTI) or acute sinusitis (AS) is ...
Nina Kassner +3 more
doaj +2 more sources
Efficacy and Safety of a Single Ivy Extract Versus Two Herbal Extract Combinations in Patients with Acute Bronchitis: A Multi-Center, Randomized, Open-Label Clinical Trial [PDF]
PharmaceuticalsBackground: The combination therapy for acute bronchitis with several plant extracts, such as Ivy and Thyme or Primrose and Thyme, is assumed to offer added benefit over single extract preparations.
Peter Kardos +4 more
doaj +2 more sources
Efficacy of EA575 as an Antitussive and Mucoactive Agent in Preclinical In Vivo Models [PDF]
BiomedicinesBackground: The efficacy of EA575 in the treatment of respiratory diseases is described in various clinical studies, improving patients’ disease-related symptoms. However, mechanistic in vivo data proving its beneficial effects are limited.
Matthias Hufnagel +4 more
doaj +2 more sources
21: Inquiries into Art, History, and the Visual, 2021 In contrast to other cultures, European Christian civilization tends to have negative emotions towards the bat, which is now suspected of having caused the Coronavirus pandemic as a virus carrier.
Philine Helas
doaj +1 more source
Monitor Versorgungsforschung, 2021 Kommentar von Dr. PH Dipl.-Stat. Carsten Schwenke (SCO:SSiS Statistical Consulting, Berlin).
Dr. PH Dipl.-Stat. Carsten Schwenke
doaj +1 more source
Einsparungen durch AMNOG-Rabatte
Monitor Versorgungsforschung, 2023 Der deutsche Gesetzgeber hat mit dem Arzneimittelmarkt-neuordnungsgesetz (AMNOG) im Jahr 2011 das Prinzip der nutzenbasierten Preisbildung gesetzlich verankert. So orientiert sich die Preisverhandlung seitdem neben den Jahrestherapiekosten vergleichbarer
Lukas Maag MSc +3 more
doaj +1 more source
Die neuen „Leitplanken“ im AMNOG-Prozess
Monitor Versorgungsforschung, 2023 Das AMNOG-Verfahren wurde in den letzten Jahren mehrfach gesetzlich angepasst. Eine wesentliche Veränderung ergab sich zuletzt mit dem Ende 2022 verabschiedeten GKV-Finanzstabilisierungsgesetz (GKV-FinStG).
Dr. PH Andrej Rasch
doaj +1 more source
Creative-Commons-Lizenzen – was ist die richtige Lizenz für mich?
GMS Medizin – Bibliothek – Information, 2022 The library of the Federal Institute for Drugs and Medical Devices (BfArM) in Bonn assists BfArM employees not only in obtaining the desired literature for scientific work, but also in publishing.
Boos, Beate, Sollmann, Anett
doaj +1 more source
Open-Access-Varianten – eine kurze Übersicht
GMS Medizin – Bibliothek – Information, 2022 The library of the Federal Institute for Drugs and Medical Devices (BfArM) in Bonn assists BfArM employees not only in obtaining the desired literature for scientific work, but also in publishing.
Boos, Beate, Sollmann, Anett
doaj +1 more source